Feasibility of contrast-enhanced mammography in women with breast implants Journal Article
| Authors: | Hogan, M. P.; Amir, T.; Mango, V. L.; Morris, E. A.; Jochelson, M. S. |
| Article Title: | Feasibility of contrast-enhanced mammography in women with breast implants |
| Abstract: | Contrast-enhanced mammography (CEM) may provide an alternative to magnetic resonance imaging as a diagnostic exam in women with known or suspected breast cancer or as a screening exam in women at increased risk of breast cancer. Women with breast augmentation, either for oncologic or cosmetic reasons, may fall into this increased risk population and need safe and effective screening and diagnostic imaging tools. Here, we present our clinical practice data in order to demonstrate the feasibility of CEM in women with breast implants. An institutional review board-approved, Health Insurance Portability and Accountability Act-compliant, retrospective review of our tertiary cancer center's database yielded 104 women with breast implants who underwent 198 CEM exams from November 2014 to March 2020. All 198/198 (100%) exams were successfully completed in 104 women. Exam indications included: 174/198 (88%) screening due to increased risk, 10/198 (5%) to evaluate a palpable abnormality, 9/198 (<5%) to evaluate disease extent following neoadjuvant chemotherapy for a known breast malignancy, and 5/198 (<3%) for a 6-month follow-up. 97/104 (93%) women had dense breasts. Routine and implant-displaced low-energy views were obtained with contrast-enhanced images obtained on displaced views for all patients. 197/198 (99.5%) exams yielded no complications. In one exam, the patient experienced mild vasovagal symptoms following the administration of contrast. In conclusion, it is feasible to utilize CEM in both diagnostic and screening capacities in women with breast implants. © 2022 |
| Keywords: | chemotherapy; magnetic resonance imaging; breast cancer; diagnostic imaging; health insurance; image enhancement; medical imaging; screening; breast implants; diseases; imaging tools; risk screening; clinical practices; institutional review boards; high-risk screening; contrast-enhanced mammography; contrast-enhanced mammographies; breast augmentations |
| Journal Title: | Clinical Imaging |
| Volume: | 93 |
| ISSN: | 0899-7071 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-01-01 |
| Start Page: | 31 |
| End Page: | 33 |
| Language: | English |
| DOI: | 10.1016/j.clinimag.2022.10.012 |
| PROVIDER: | scopus |
| PUBMED: | 36371851 |
| PMCID: | PMC10445338 |
| DOI/URL: | |
| Notes: | Article -- The NIH/NCI Cancer Center Support Grant P30 CA008748 is acknowledged in the PDF -- Corresponding author is MSK author Molly P. Hogan -- Export Date: 1 December 2022 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work